A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells
- PMID: 1451350
- DOI: 10.1007/BF00133469
A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells
Abstract
A new model for the study of spontaneous bone metastasis has been developed which allows for the quantification of metastatic tumor burden and cancer cell growth rate, and which describes the progressive changes in bone morphology. Walker 256 (W256) cells or vehicle were injected into the left upper thigh muscle of male Fischer rats, which were killed 7, 10 or 14 days later. By day 7, metastases had appeared in the distal femur, in the glomeruli of the kidney, and diffusely throughout the liver and lungs. The extent of tumor burden in these organs increased over time. In the femur, 14 days of tumor burden was associated with a 53 +/- 10% decrease in trabecular bone content, a 61 +/- 15% increase in osteoclast surface, and a 95 +/- 10% decrease in osteoblast surface, as compared with non-tumor-bearing controls. By autoradiography, metastatic tumor cells in all organs were determined to have greater growth rates than did cells in the primary tumor. However, within the femur, W256 cells located adjacent to trabecular bone surfaces had a 33 +/- 7% greater growth rate than did W256 cells located > 50 microns from bone surfaces (P < 0.05), suggesting a mitogenic effect of bone.
Similar articles
-
Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone.Clin Exp Metastasis. 1992 Nov;10(6):411-8. doi: 10.1007/BF00133470. Clin Exp Metastasis. 1992. PMID: 1451351
-
Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats.Cancer Res. 1993 Nov 15;53(22):5452-7. Cancer Res. 1993. PMID: 8221685
-
Effect of alpha tocopherol acetate in Walker 256/B cells-induced oxidative damage in a rat model of breast cancer skeletal metastases.Chem Biol Interact. 2009 Dec 10;182(2-3):98-105. doi: 10.1016/j.cbi.2009.09.010. Epub 2009 Sep 23. Chem Biol Interact. 2009. PMID: 19781538
-
Relations between radiograph texture analysis and microcomputed tomography in two rat models of bone metastases.Cells Tissues Organs. 2006;182(3-4):182-92. doi: 10.1159/000093967. Cells Tissues Organs. 2006. PMID: 16914920
-
Animal models of bone metastasis.Cancer. 2003 Feb 1;97(3 Suppl):748-57. doi: 10.1002/cncr.11150. Cancer. 2003. PMID: 12548572 Review.
Cited by
-
Osteoclast Signal Transduction During Bone Metastasis Formation.Front Cell Dev Biol. 2020 Jun 19;8:507. doi: 10.3389/fcell.2020.00507. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32637413 Free PMC article. Review.
-
Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion.Ther Adv Med Oncol. 2011 Sep;3(5):233-43. doi: 10.1177/1758834011412656. Ther Adv Med Oncol. 2011. PMID: 21957430 Free PMC article.
-
Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications.Cancer Immunol Immunother. 2011 Mar;60(3):305-17. doi: 10.1007/s00262-011-0974-x. Epub 2011 Jan 18. Cancer Immunol Immunother. 2011. PMID: 21243489 Free PMC article. Review.
-
Mechanisms involved in the metastasis of cancer to bone.Breast Cancer Res Treat. 1993;25(2):151-63. doi: 10.1007/BF00662140. Breast Cancer Res Treat. 1993. PMID: 8347847 Review.
-
Transforming growth factor beta upregulates the integrin-mediated adhesion of human prostatic carcinoma cells to type I collagen.Clin Exp Metastasis. 1997 Jan;15(1):41-52. doi: 10.1023/a:1018484323210. Clin Exp Metastasis. 1997. PMID: 9009105
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical